APC Reconstruction for Massive Bone Loss
- An allograft-prosthetic composite (APC) is a reconstruction that combines a structural bulk ALLOGRAFT with a PROSTHESIS: the allograft restores the missing segment of bone (bone stock) and provides a biological surface for SOFT-TISSUE and TENDON reattachment, while the prosthesis, cemented or fixed within the allograft, provides the articular (joint) surface - so the construct reconstructs both the bone and the joint.
- APCs are used for MASSIVE SEGMENTAL bone and joint loss that cannot be managed by standard implants: after bone TUMOUR resection (as part of limb salvage), in failed REVISION arthroplasty with massive bone loss, and in periprosthetic fracture with bone loss; common sites are the PROXIMAL FEMUR, PROXIMAL TIBIA, PROXIMAL HUMERUS and DISTAL FEMUR.
- The principal ADVANTAGE of an APC over a megaprosthesis (tumour endoprosthesis) alone is BIOLOGICAL: it restores host bone stock through host-allograft union and, critically, provides a biological attachment site for the SOFT TISSUES - for example the hip abductors at the proximal femur, the EXTENSOR MECHANISM (patellar tendon) at the proximal tibia, and the rotator cuff/deltoid/subscapularis at the proximal humerus - which can improve function and stability.
- These soft-tissue advantages are why an APC is often favoured at sites where tendon reattachment matters and in YOUNGER patients in whom preserving/restoring bone stock for the future is valuable, whereas a megaprosthesis offers faster reconstruction, immediate weight-bearing and no reliance on graft union (favoured in older/lower-demand patients or where rapid recovery is needed).
- The COMPLICATIONS are dominated by ALLOGRAFT-related problems: NONUNION at the host-allograft junction, allograft RESORPTION, allograft FRACTURE, and INFECTION (the allograft is avascular and at higher infection risk), plus the usual prosthetic complications (instability, loosening) and a small risk of disease transmission; reported series show good functional outcomes but a substantial complication burden, with union typically taking several months.
- OUTCOMES in selected patients are favourable - for example, in reverse shoulder arthroplasty for massive proximal humeral bone loss an APC gives substantial improvement in pain and motion with high (around 96% at 2-5 years) revision-free survival and reliable host-allograft union - but the technique is technically demanding and the high complication rate means careful patient selection, meticulous junction fixation/union, and infection vigilance are essential.
- “APC = structural bulk ALLOGRAFT (restores bone stock + biological SOFT-TISSUE/tendon reattachment) + a PROSTHESIS (joint surface), for MASSIVE segmental bone loss (tumour, failed revision, periprosthetic).
- “Advantage over megaprosthesis: restores BONE STOCK + allows tendon attachment (abductors / extensor mechanism / cuff-deltoid) - favoured in younger patients / where soft-tissue attachment matters. Megaprosthesis = faster, immediate WB, no union needed (older/low-demand).
- “Complications are allograft-related: junctional NONUNION, RESORPTION, FRACTURE, INFECTION (avascular graft) - technically demanding, high complication burden, good outcomes in selected patients.
A bulk allograft (bone stock + soft-tissue/tendon attachment) plus a prosthesis (joint surface), for massive segmental bone loss (tumour, failed revision, periprosthetic).
Restores bone stock and tendon attachment (vs a megaprosthesis) - but is technically demanding with allograft complications (junctional nonunion, resorption, fracture, infection).
Concept, Indications & APC vs Megaprosthesis
An allograft-prosthetic composite (APC) combines a structural bulk allograft (which restores bone stock and provides a biological surface for soft-tissue/tendon reattachment) with a prosthesis fixed within it (providing the articular surface), to reconstruct massive segmental bone and joint loss - after tumour resection, failed revision arthroplasty, or periprosthetic bone loss - commonly at the proximal femur, proximal tibia, proximal humerus or distal femur. Its advantage over a megaprosthesis is biological: it restores bone stock (host-allograft union) and allows attachment of key soft tissues (hip abductors, the extensor mechanism at the proximal tibia, the cuff/deltoid at the proximal humerus), making it attractive in younger patients. The trade-off is that it is technically demanding, costly, and has allograft-related complications - junctional nonunion, resorption, fracture and infection (the graft is avascular).
| Feature | Allograft-prosthetic composite | Megaprosthesis |
|---|---|---|
| Bone stock | Restored (host-allograft union) | Not restored (bone resected, replaced by metal) |
| Soft-tissue/tendon attachment | Biological (tendon-to-allograft) - a key advantage | Synthetic/limited (tendon-to-metal) |
| Speed / weight-bearing | Slower (needs union) | Faster; immediate weight-bearing |
| Best for | Younger patients; sites needing tendon attachment; bone-stock restoration | Older/lower-demand; rapid recovery; poor union potential |
| Main complications | Junctional nonunion, resorption, allograft fracture, infection | Aseptic loosening, infection, mechanical failure |
Sites, Complications & Outcomes
- Site-specific soft-tissue advantage: proximal femur (abductor reattachment for stability/function), proximal tibia (extensor mechanism/patellar tendon reattachment - a major advantage over a megaprosthesis), proximal humerus (rotator cuff/deltoid/subscapularis repair - improves a reverse arthroplasty), distal femur.
- Achieve and protect union: secure host-allograft junction fixation (plate/compression) and biology; union typically takes several months, during which the construct is protected.
- Anticipate allograft complications: junctional nonunion, allograft resorption, allograft fracture, and infection (avascular graft, higher risk) - with a small disease-transmission risk; counsel and monitor.
- Select the patient: APC for younger patients / where tendon attachment matters; megaprosthesis where speed, immediate weight-bearing or poor union potential favour it.
- Outcomes: good function in selected patients (e.g. high revision-free survival and reliable union in proximal-humeral APC reverse arthroplasty), but a substantial complication burden demands expertise."
The defining feature of an allograft-prosthetic composite is that the allograft provides what a megaprosthesis cannot - restored bone stock and a biological surface for tendon and soft-tissue reattachment - but the same allograft is the source of the construct's characteristic complications, because it is avascular: it can fail to unite at the host-allograft junction, resorb, fracture, and is at higher risk of infection, with a small risk of disease transmission. So an APC should be chosen when its biological advantages genuinely matter - in younger patients, and at sites where tendon reattachment (the extensor mechanism, abductors, rotator cuff) is critical - and the surgeon must secure and protect the host-allograft junction to achieve union, respect the graft's fragility, and maintain infection vigilance. Where speed, immediate weight-bearing or poor union potential dominate, a megaprosthesis may be the better choice.
Evidence & Key Studies
APC reconstruction for massive proximal humeral bone loss in reverse shoulder arthroplasty
- An allograft-prosthetic composite restores proximal humeral bone, restores humeral length, allows deltoid tensioning and provides for repair of the rotator cuff and subscapularis - improving strength and stability in reverse arthroplasty.
- In 26 reverse arthroplasties (primary and revision) using an APC, pain, elevation and external rotation improved significantly, with no revision for host-allograft nonunion (mean union 7 months) and a 2-5 year revision-free survival of 96%.
- APCs are costly, technically demanding and can be compromised by allograft resorption, but are safe and effective for massive proximal humeral bone loss in selected patients.
Resurfaced allograft-prosthetic composite for distal femur reconstruction in children with bone tumour
- A resurfaced allograft-prosthetic composite preserved bone stock and the proximal tibial physis after distal femoral sarcoma resection in children, minimising limb-length discrepancy at skeletal maturity.
- Patients who retained the original reconstruction had excellent function (MSTS ~29.5) and good knee motion, but complications (deep infection requiring removal, allograft fracture) occurred in 2 of 4.
- APC is a viable bone- and physis-preserving option in selected young patients despite a high risk of complications.
According to PubMed, the biological advantages of an APC (restoring bone, restoring length, allowing deltoid tensioning and rotator-cuff/subscapularis repair), the good functional outcomes with reliable host-allograft union (96% revision-free survival, mean union 7 months) and the concern of allograft resorption come from the cited Sanchez-Sotelo proximal-humeral series; the bone- and physis-preserving advantage in children after tumour resection and the high complication rate (infection, allograft fracture) from the cited Errani distal-femur series. The APC-versus-megaprosthesis trade-offs, the site-specific soft-tissue (extensor mechanism, abductor) advantages, and the allograft-related complication profile (junctional nonunion, resorption, fracture, infection) are standard, well-established teaching. (See also our Megaprosthesis / Endoprosthetic Replacement and Limb Salvage topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“What is an allograft-prosthetic composite and when is it used?”
“What are the complications of an APC, and how does it compare with a megaprosthesis?”
Mnemonics & Memory Aids
APC
Hook:APC: Allograft (bone + tendon attachment), Prosthesis (joint surface), Composite for massive loss (Complications: nonunion/resorption/fracture/infection).
What it is
- Structural bulk allograft + prosthesis
- Allograft: restores bone stock + biological soft-tissue/tendon attachment
- Prosthesis: provides the articular (joint) surface
Indications & sites
- Massive segmental bone/joint loss: tumour resection, failed revision, periprosthetic loss
- Sites: proximal femur, proximal tibia, proximal humerus, distal femur
- Younger patients / where tendon reattachment matters
APC vs megaprosthesis
- APC: restores bone stock + tendon attachment; slower (needs union)
- Megaprosthesis: faster, immediate weight-bearing, no union needed
- Choose by age/demand, soft-tissue needs, union potential
Complications
- Allograft: junctional nonunion, resorption, fracture, infection (avascular)
- Small disease-transmission risk; + prosthetic instability/loosening
- Good outcomes in selected patients but high complication burden